Premium
Uterus human leucocyte antigen expression in the perspective of transplantation
Author(s) -
Gauthier Tristan,
Filloux Matthieu,
Guillaudeau Angelique,
Essig Marie,
Bibes Romain,
Pacha Adam Fodil,
Piver Pascal,
Aubard Yves,
Marquet Pierre,
Drouet Mireille
Publication year - 2016
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/jog.13107
Subject(s) - uterus , myometrium , human leukocyte antigen , endometrium , medicine , transplantation , antigen , immunochemistry , immunohistochemistry , immunology , andrology , pathology , antibody
Aim To describe class I and II human leucocyte antigen (HLA) expression using different uterine tissues in the perspective of uterus transplantation. Methods Human uterine tissues were obtained from 12 women who had undergone hysterectomy for the treatment of benign disease. HLA class I and HLA‐antigen D related (DR) expression were assessed via immunochemistry. HLA class I expression in the uterus was compared with expression in other organs and tissues, including kidney and myocardium samples. Results HLA class I expression was strong in the endometrial glands and mild in the myometrium. Staining of endometrial glands was similar to glomerular staining in the kidney. The myometrium seems to express HLA class I similarly to hepatocytes and myocardial cells. HLA class I expression in the uterus did not differ in younger or post‐menopausal women. HLA‐DR was expressed in the endometrial glands, but not in the myometrium. A lack of HLA‐DR expression seemed to be correlated with cell proliferation. Conclusion HLA expression in the endometrium and myometrium is different. The endometrium should be the major target of alloreactive response. As for other transplanted organs, assessment of HLA unacceptable antigens and multiple immunosuppressive treatments is necessary in uterus transplantation.